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ABSTRACT  
Cocaine addiction is a chronic relapsing disorder characterized by the loss of control over drug-
seeking and taking, and continued drug use regardless of adverse consequences. Despite years of 
research, effective treatments for psychostimulant addiction have not been identified. Persistent 
vulnerability to relapse arises from a number of long lasting adaptations in the reward circuitry that 
mediate the enduring response to the drug. Recently, we reported that the activity of the canonical or 
Wnt/β-catenin pathway in the Prefrontal Cortex (PFC) is very important in the early stages of 
cocaine-induced neuroadaptations.  In the present work, our main goal was to elucidate the relevance 
of this pathway in cocaine-induced long-term neuroadaptations that may underlie relapse. We found 
that a cocaine challenge, after a period of abstinence, induced an increase in the activity of the 
pathway which is revealed as an increase in the total and nuclear levels of β-catenin (final effector of 
the pathway) in the Nucleus Accumbens (NAcc), together with a decrease in the activity of Glycogen 
synthase kinase 3β (GSK3β). Moreover, we found that the pharmacological modulation of the activity 
of the pathway has long-term effects on the cocaine-induced neuroplasticity at behavioral and 
molecular levels. All the results imply that changes in the Wnt/β-catenin pathway effectors are long-
term neuroadaptations necessary for the behavioral response to cocaine. Even though more research is 
needed, the present results introduce the Wnt canonical pathway as a possible target to manage 
cocaine long-term neuroadaptations. 
  
INTRODUCTION  
Cocaine addiction is a chronic relapsing disorder characterized by the loss of control over drug-
seeking and taking, and continued drug use regardless of adverse consequences (APA 2000). Over the 
years, different animal models have been designed to contribute to the elucidation of the 
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neurobiological processes involved in relapse behavior and to evaluate potential pharmacotherapies 
that may prevent or reduce the risk of relapse (LaCrosse et al. 2016). However, despite almost 50 
years of experimental research, effective treatments for psychostimulant addiction have not been 
identified. The persistent vulnerability to relapse arises from a number of temporary plastic changes 
that eventually lead to long lasting adaptations that mediate the hypersensitivity and enduring 
response to the drug (Vanderschuren & Kalivas 2000). Abundant evidence suggests that the Nucleus 
Accumbens (NAcc) is the locus in the reward circuit where drugs induced the long-term changes that 
underlie cocaine addiction. The NAcc core receives innervations from the Prefrontal Cortex (PFC) 
and the Ventral Tegmental Area (VTA). Both glutamatergic and dopaminergic afferents regulate 
various motivated behaviors thought to model different aspects of drug addiction, including locomotor 
sensitization, conditioned place-preference (CPP), intravenous self-administration, and reinstated drug 
seeking (Feltenstein & See 2008, Robinson & Berridge 2000, Sesack & Grace 2010, Stewart et al. 
1984, Stuber et al. 2012). In fact, the pharmacological or the optogenetic inhibition of the NAcc core 
(McFarland & Kalivas 2001, Stefanik et al. 2013), as well as the inhibition of its afferents from the 
dorsal medial PFC, attenuate the behavioral manifestation of cocaine neuroadaptations (i.e. 
sensitization (Anderson et al. 2003, Pierce et al. 1998), and reinstatement (McFarland et al. 2003)). 
Among other changes, cocaine induces a decrease in basal glutamate levels in the NAcc that increase 
after a cocaine challenge (Baker et al. 2003, Pierce et al. 1996), which in turn by acting on the AMPA 
(alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate) receptors (AMPAR) promotes higher 
behavioral responses (Cornish & Kalivas 2000, Pierce et al. 1996). Also, withdrawal from drug 
exposure induces changes in NAcc neurons which can be temporarily reversed by re-exposure to the 
drug. For instance, during cocaine withdrawal there is an increase in synaptic strength of AMPA 
relative to NMDA-mediated current given by an increase in the surface expression of AMPAR 
(Kourrich et al. 2007, Boudreau et al. 2007, Wolf & Ferrario 2010), and changes in dendritic spine 
density (Robinson & Kolb 2004, Russo et al. 2010, Shen et al. 2014, Shen et al. 2009). While the 
mechanisms that regulate these structural changes are not clear, the regulation of the actin 
cytoskeleton appears to be involved  (Toda et al. 2006, Toda et al. 2010) as well as the activity of 
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small GTPase and the induction of different genes and their targets (eg ΔFosB, NFkB, Cdk5-MEF2, 
etc) (Russo et al. 2010). 
Recently, we reported that the activity of the Wnt canonical pathway in the PFC is implicated in 
facilitating the induction of behavioral sensitization (Cuesta et al. 2016). Together with our results, in 
the past decade, mounting evidence has suggested a link between dysfunction of Wnt signaling and 
neurological disorders such as Alzheimer's disease, bipolar disorder and schizophrenia (Kozlovsky et 
al. 2002, De Ferrari & Inestrosa 2000). The Wnt growth factors belong to a large family of secreted 
proteins, that can signal through different receptors including Frizzled (Fz), the atypical tyrosine 
kinase receptors Ror, Ryk, and PTK7(Clevers & Nusse 2012, Anastas 2015, Oliva et al. 2013) as well 
as IGF-1R (Bernis et al. 2013). The interaction between Wnt and Fz leads to the phosphorylation of 
Dishevelled (Dvl, first intracellular effector). Downstream of Dvl, the Wnt pathways diverge into 
three branches: the canonical or Wnt/β-catenin, the planar cell polarity and the Wnt/calcium pathways 
(Oliva et al. 2013, Ciani & Salinas 2005). The activation of the canonical pathway results in the 
phosphorylation of GSK3β (Glycogen synthase kinase 3β) leading to β-catenin stabilization and 
subsequent entrance to the nucleus where it promotes gene expression (Clevers & Nusse 2012, 
Metcalfe & Bienz 2011). While in the absence of Wnt, GSK3β phosphorylates β-catenin marking it 
for degradation by the proteasome (Maguschak & Ressler 2012). We, and others, have suggested that 
regulation of GSK3β activity might be associated with cocaine-induced neuroadaptations. Not only 
does cocaine produce changes in GSK3β activity, but also inhibitors of GSK3β, both targeted (e.g., 
SB 216763) and non-selective (e.g., valproate or lithium chloride), prevent the development  (Cuesta 
et al. 2016) as well as the expression of behavioral sensitization (Xu et al. 2009).  However, the 
relationship between the long-term effects of cocaine, GSK3β and the Wnt/β-catenin pathway has not 
been explored. Therefore, our main goal was to evaluate whether the Wnt canonical pathway is 
involved in long-term cocaine-induced neuroadaptations. In the present study, we combined 
molecular, pharmacological and behavioral studies in order to evaluate the relevance of the Wnt/β-
catenin pathway for cocaine-induced neuroadaptations that may underlie the persistence of addiction, 
looking also into the possibility of considering this pathway as a pharmacological target for addiction.  
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METHODS   
Experimental subjects 
Male Wistar rats (250–330 g) were purchased from the Vivarium of the Facultad de Ciencias 
Bioquímicas y Farmaceúticas (Universidad Nacional de Rosario, UNR, Argentina). Rats were group 
housed in the colony room for at least 7 days before experimental tests started, with food and water ad 
libitum. All experiments were conducted during the light period of a 12hrs light/dark cycle and were 
completed in accordance with the guidelines established by the Institutional Animal Care and Use 
Committee at the Facultad de Ciencias Bioquímicas y Farmaceúticas - UNR.   
 
Drugs 
Cocaine hydrochloride was purchased from Droguería Saporiti (Buenos Aires, Argentina), while 
Lithium Chloride (LiCl) was obtained from Sigma (St. Louis, MO). Cocaine was dissolved in saline 
while LiCl was in ultrapure water.  
 
Behavioral Tests 
Motor Activity. The testing apparatus consisted of 8 acrylic boxes (43x43x30cm) equipped with 8 
infrared photocell beams located 3cm above the floor. Interruption of any beam resulted in a photocell 
count. Locomotor activity was recorded during 1hr habituation and the 2hrs immediately after the 
injection. The apparatus and its software were developed by Laboratorio de Investigación Aplicada y 
Desarrollo, Facultad de Ciencias Exactas, Físicas y Naturales (Universidad Nacional de Córdoba, 
Argentina). 
 
Tissue preparation 
Rats were euthanized 3 or 24hrs after the last injection of cocaine or saline, and their brains were 
removed. The NAcc, PFC, and Caudate Putamen (CPu) were dissected according to Heffner et al. 
(1980) using a rat brain matrix. Tissue was kept at -80ºC until analysis.  
Total Homogenates. Tissues were homogenized on ice with RIPA buffer supplemented with 
phosphatase and protease inhibitors (2 µg/ml aprotinin; 2 µg/ml leupeptin; 1 µg/ml pepstatin; 100 
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µg/ml PMSF; 1 mM Na3VO4; 50 mM NaF), and centrifuged for 5 min at 13,000 g. Protein 
concentration was measured using the Lowry assay. 
Subcellular Fractionation. In a different set of animals, brain tissue was dissected and subcellular 
fractionation was performed as previously described by Cuesta et al (2016).  
 
Western Blotting 
Protein extracts coming from total homogenates or nuclear fractions were heated to 80°C for 5 min 
with Laemmli buffer as a reducing treatment. Samples (total homogenate: 10μg/lane; nuclear fraction: 
5μg/lane) were run in 10% SDS-polyacrylamide gel and transferred to nitrocellulose membrane. A 
secondary horseradish peroxidase-conjugated antibody (Sigma, St. Louis, MO) followed overnight 
incubation with primary antibody (β-catenin (MW 92KDa) 1:10000, phospho-GSK3β-Y216 1:8000, 
total GSK3β (MW 46KDa) 1:10000; BD BioScience, San Jose, California). Reactivity was detected 
using enhanced chemiluminescence (ECL) and quantified using Gel-Pro Plus software package. Total 
homogenates blots were also incubated with anti-tubulin ((MW 50KDa) 1:14000; Sigma, St. Louis, 
MO) or total GSK3β to correct for differences in protein loading.  
 
Experimental procedures  
Acute cocaine, chronic cocaine and saline treatments. 
Subjects were assigned to one of three conditions: saline, acute cocaine, or chronic cocaine (Fig 1A). 
All animals received one injection per day for 7 days, 3 weeks of abstinence and a final challenge on 
day 28. Saline group: animals received saline (1 ml/kg i.p). Acute cocaine: rats received saline (1 
ml/kg i.p) on days 1 to 7, and cocaine (15 mg/kg i.p) on day 28. Chronic cocaine: animals received 
15 mg/kg cocaine (i.p) on days 1, 7 and 28; and 30 mg/kg cocaine (i.p) on days 2 to 6. Locomotor 
activity was recorded after injections on days 1, 7 and 28. From days 2 to 6, animals were injected in 
their home cages without locomotor activity recording. For the purposes of our study  we separated 
animals receiving chronic cocaine into sensitized and non-sensitized groups, according to their 
locomotor responses (Fig 1B); where cocaine-induced sensitization was defined as a minimum of 
20% increase in total activity counts on day 28 compared to day 1 (Pierce et al. 1996). 
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Animals were sacrificed 24hs after the last cocaine/saline challenge. Their brains were removed and 
dissected.   
 
LiCl pretreatments. 
Animals received LiCl (30 mg/kg i.p.) or Saline (1 ml/kg i.p.) injections 30min before each saline or 
cocaine injection (from day 1 to 7), leading to four groups: Saline/Saline, LiCl/Saline, Saline/Cocaine, 
and LiCl/Cocaine. After three weeks of abstinence, on day 28, each group was divided into two 
subgroups to receive a challenge with cocaine (15 mg/kg i.p.) or saline (1 ml/kg i.p.) (Fig 4A). The 
dose of LiCl was chosen based on our previous work (Cuesta et al. 2016). Locomotor activity was 
recorded on days 1, 7 and 28. Animals were sacrificed 24hs after the last cocaine/saline challenge. 
Their brains were removed and dissected.   
 
Data Analysis 
Locomotor activity was analyzed using two-way or three-way analysis of variance (ANOVA) with 
pretreatment, treatment and time as main factors. Western blots were analyzed using either a t test or a 
1-way analysis of variance (one-way ANOVA). In all cases, the ANOVA was followed by a post hoc 
test with significance set at p < 0.05, depending on the number of groups under consideration. 
 
RESULTS 
Long-term cocaine-induced neuroadaptations lead to changes in β-catenin expression in NAcc and 
CPu 
In order to investigate the potential role of Wnt/β-catenin pathway on the long-lasting effects of 
chronic cocaine, we treated the rats with a cocaine regime that produces robust psychomotor 
sensitization (Cuesta et al. 2016, Pierce et al. 1996, Boudreau et al. 2007). Since it has been 
previously shown that a percentage of the cocaine treated animals may not manifest psychomotor 
sensitization (Cuesta et al. 2016, Pierce et al. 1996, Boudreau et al. 2007), we challenged the animals 
with a cocaine injection 3 weeks after the end of the chronic treatment. The brain areas of the control 
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groups (saline and acute cocaine) as well as the ones of the animals that showed behavioral 
sensitization were collected after 3 or 24hs of the last injection; the animals of the chronic group that 
did not show behavioral sensitization were sacrificed after 24hs. Thus, we started by comparing β-
catenin levels, the final effector of the canonical Wnt pathway, as a readout of the activity of the 
pathway in rats that behaviorally showed the psychomotor sensitization after a chronic cocaine 
treatment against control animals (acute cocaine and saline groups). A one-way ANOVA analysis of 
data collected 24hrs after the last injection on day 28 revealed a significant effect of treatment in the 
NAcc [F(2, 19) = 20.53; p< 0.001] (Fig 2A) and CPu [F(2, 17) = 6.54; p< 0.001] (Table 1A). The post 
hoc analysis revealed that β-catenin levels were significantly increased in the NAcc, while decreased 
in the CPu of animals that showed behavioral sensitization compared to control animals. In contrast 
with our previous results (Cuesta et al. 2016), no changes were found in the PFC after the challenge 
on day 28 (Table 1A). The evaluation of β-catenin expression in animals that were sacrificed 3hrs 
after the last cocaine injection, turned out to be similar to 24hs (Table 1B). Regarding the acute group, 
it is important to highlight that, as we expected, β-catenin was not different from saline neither at 24hs 
nor at 3hs after the last injection. So far, these results suggested that a cocaine challenge on day 28 
leads to changes in β-catenin levels specifically in the NAcc and CPu of animals that showed long-
term adaptations related to an increased behavioral response to cocaine. To study whether those 
changes in β-catenin were a neuroadaptation necessary for the behavioral manifestation to occur, we 
compared the levels of β-catenin in brain areas obtained from sensitized animals (S) with non-
sensitized animals (NS) and the control group (saline animals), after receiving the corresponding 
challenge on day 28. A one-way ANOVA analysis of the data revealed a significant effect of the 
behavioral response on β-catenin levels in the NAcc [F(2, 17) = 10.17; p < 0.01] (Fig 2B), and the 
CPu [F(2, 17) = 7.73; p < 0.005] (Table 1C), while no differences were found between the groups in 
the PFC (Table 1C). These results showed that in the NAcc and the CPu, changes in β-catenin levels 
are a characteristic neuroadaptation for the behavioral expression of sensitization. Then, we 
investigated if those changes were present before the cocaine challenge on day 28 or were a result of 
it. To do that, we compared β-catenin levels in saline control animals regarding animals that received 
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a cocaine treatment during 7 days, sensitized and were challenged with saline (Coc/Sal) or cocaine 
(Chronic) on day 28. A one-way ANOVA analysis of data revealed a significant effect of the 
challenge on day 28 on β-catenin levels in the NAcc [F (2, 16) = 16.11; p<0.0001] (Fig 2C), CPu [F 
(2, 15) = 61.23; p<0.0001], and PFC [F (2, 20) = 5.712; p<0.05] (Table 1D). These data showed that 
β-catenin levels in the animals that sensitized were different depending on the presence or absence of 
cocaine: in the NAcc while the levels of β-catenin remain unmodified after the saline challenge 
regarding the saline control group, the injection of cocaine induced an increase; at the same time the 
levels of β-catenin in the CPu and the PFC of animals’ challenge with saline were higher than 
controls, and cocaine induced a decrease. It is important to note here that the Coc/Sal group has been 
re-exposed to the context where cocaine was administered, which may produce the expectation to the 
cocaine injection usually reflected as hyperlocomotion. Even though, there is previous evidence that 
the same cocaine treatment induced conditioned locomotion after two weeks of withdrawal (Boudreau 
et al. 2007),we did not find significant differences when comparing the response to saline in animals 
previously treated with cocaine or saline after three weeks of withdrawal (Fig 4B). In summary, we 
found that β-catenin levels in the NAcc increase while decrease in the CPu in response to a cocaine 
challenge only in the animals that expressed cocaine-induced neuroadaptations at a behavioral level. 
Moreover, the fact that β-catenin expression is not modified in the NAcc and it is increased in the 
PFC, and the CPu before the cocaine challenge strengthens the idea that the chronic cocaine treatment 
induces long-term neuroadaptations in the effectors of the Wnt/β-catenin pathway that allow the 
behavioral display of sensitization. 
 
Cocaine-induced behavioral neuroadaptations are associated with a functional increase of β-
catenin in the NAcc  
Considering previous evidence that supports an important role of the NAcc in the long lasting cocaine 
neuroadaptations that underlie sensitization and addiction, we deepened our study evaluating if the 
changes in β-catenin levels found in total homogenates of sensitized animals were the result of a 
functional increase of the Wnt canonical pathway. Consequently, we first compared the GSK3β 
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activity levels in the NAcc of chronic cocaine sensitized animals and saline controls. Fig 3A showed 
GSK3β activity levels in the NAcc evaluated as the phosphorylation level of Tyrosine 216 (activator 
site). No changes were found in total GSK3β protein levels (t test, p = 0.14). However, the ratio 
GSK3β(Y216):GSK3β total was significantly decreased in chronic cocaine animals compared to 
saline (t test, p < 0.05), proposing a reduction in GSK3β activity which is in line with the increase in 
β-catenin levels found in the NAcc after the expression of cocaine-induced sensitization. Then, fresh 
brain tissue obtained from another set of animals was subjected to subcellular fractionation and β-
catenin was measured in the nuclear fraction (Fig 3B). Our data showed that β-catenin levels were 
increased in the nuclear fraction of the NAcc of sensitized animals (t test, p < 0.05).  These results 
suggest that the behavioral manifestation of cocaine-induced neuroadaptations can be linked to a 
functional increase of Wnt/β-catenin pathway in the NAcc. 
 
A repeated treatment with systemic Lithium Chloride along with cocaine blocks the long lasting 
cocaine–induced neuroadaptations at the behavioral level by changing β-catenin expression in the 
NAcc 
In our previous work, we demonstrated that a repeated treatment with LiCl (a nonspecific inhibitor 
of GSK3β activity) previous to a cocaine injection blocked sensitization preventing changes in β-
catenin levels when measured at the end of the chronic cocaine treatment (Cuesta et al. 2016). Taking 
into account the results presented here we set to determine if LiCl would have a long lasting effect on 
the behavioral and molecular response to cocaine. In order to evaluate this, we treated animals with 
LiCl (30 mg/kg i.p.) or Saline before each cocaine injection during day 1 to 7 (Fig. 4A). Interestingly, 
we found that LiCl blocked the increased behavioral response associated with the expression of 
sensitization conducted three weeks after the pretreatment (Fig. 4B) and induced different long-term 
neuroadaptations in β-catenin levels in NAcc, CPu and PFC total homogenates (Fig. 5). It is important 
to mention that animals pretreated with LiCl did not show the development of  cocaine- induced 
sensitization (total activity Day 1= 6058 ± 360.27; Day 7= 5940 ± 749.7), as it was previously 
demonstrated (Cuesta et al. 2016). A three-way ANOVA analysis applied to the behavioral response 
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on day 28 showed in Fig. 4B revealed a significant main effect of challenge [F (1,49) = 118.69, p < 
0.0001], treatment [F(1,49) = 13.79, p < 0.01], and a significant interaction between pretreatment x 
treatment x challenge [F(1, 49) = 4.28 p < 0.05]. The post hoc analysis revealed that, regardless of the 
pretreatment, the animals showed an increase in their locomotor response compared to the control 
animals (Sal/Sal/Sal) when they had received cocaine. However, only the animals pretreated with 
saline showed a significant increase in their locomotor response when comparing the chronic 
treatment to the acute one. In fact, the response to the cocaine challenge in the chronic cocaine group 
pretreated with saline was significantly higher than the same response to cocaine in the group 
pretreated with LiCl. Moreover, when we pretreated this last group with LiCl they showed, on day 28, 
similar behavioral responses when comparing acute to chronic cocaine. These results indicate that a 
treatment with LiCl before cocaine injections has long-term effects on the locomotor response to a 
cocaine challenge after three weeks of abstinence, since these animals were unable to express 
behavioral sensitization. 
 
After 24hs from the last injection on day 28, all the animals were sacrificed and β-catenin was 
measured in total homogenates from the NAcc, CPu and CPF (Fig 5). A three-way ANOVA analysis 
of data in Fig 5 revealed the following results for each brain area. In the NAcc (Fig 5) the analysis 
displayed a main effect of pretreatment [F(1,44) = 33.5, p < 0.001], and challenge [F(1,44) = 6.301, p 
< 0.05]. The post hoc analysis showed a significant increase in β-catenin levels in the NAcc of 
animals that expressed behavioral sensitization as well as in all the groups that received a LiCl 
pretreatment compared to the control group (Sal/Sal/Sal).  Meanwhile, in the CPu (Table 2) β-catenin 
levels showed a significant main effect of interaction between pretreatment x treatment x challenge 
[F(1,44)= 34.56, p < 0.0001]. The post hoc analysis revealed significant changes on the β-catenin 
levels before and after the cocaine challenge, with an increase (Sal/Coc/Sal) before the challenge and 
a decrease (Sal/Coc/Coc) after, compared to saline animals. Importantly, the pretreatment with LiCl 
blunted all this modification in β-catenin levels. Finally, in PFC (Table 2) β-catenin levels showed a 
significant main effect of interaction pretreatment x treatment [F (1,41)= 4.85, p < 0.05]. The post hoc 
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analysis only showed a significant increase in β-catenin levels in the PFC of abstinent animals 
(Sal/Coc/Sal) compared to controls with no changes in β-catenin levels in the PFC of the LiCl 
pretreated animals.  
 
DISCUSSION   
Identifying new targets for therapeutic treatment of addiction has been one of the main foci for drug 
abuse research during the last decades. In the current study, we contribute to this goal by proposing a 
novel role of the Wnt/β-catenin pathway in cocaine-induced long-term neuroadaptations. Our main 
findings showed: 1) that chronic cocaine induced an increase on the levels of β-catenin (final effector 
of the pathway) in the NAcc, a decrease in the CPu and no changes in the PFC, compared to saline 
treated animals; 2) that those changes were present only in animals where chronic cocaine induced 
neuronal adaptations were evident at a behavioral level after a cocaine challenge; 3) that long-term 
effects of cocaine are related  to an increased activity of the Wnt/β-catenin pathway in the NAcc, and, 
4) that a pharmacological modulation of the pathway activity has a long-term effect on cocaine-
induced neuroplasticity. Taken together, these results suggest that changes in the Wnt/β-catenin 
pathway effectors are long-term neuroadaptations required for the behavioral response to cocaine.  
 
Long-term cocaine-induced neuroadaptations lead to changes in Wnt/β-catenin pathway   
To our knowledge, this is the first time that the Wnt/β-catenin pathway is associated with cocaine-
induced long-term neuroadaptations. While other groups have demonstrated that cocaine treatments 
induce changes in GSK3β activity, no one has either connected them to the Wnt canonical pathway or 
evaluated them after 3 weeks of abstinence. For instance, and in line with our results, it has been 
shown that an acute injection of cocaine induced an increase of GSK3β activity in the CPu of mice 
(Miller et al., 2009), that can be linked to cocaine-induced CPP (Miller et al. 2014). Furthermore, in 
both studies cocaine behavioral effects were prevented with a specific GSK3β inhibitor (SB216763). 
On the other hand, two recent works found an increased activity of GSK3β only in the NAcc core 
after acute cocaine (Miller et al. 2014) and 2 weeks after chronic cocaine treatment in drug-free rats 
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(Kim et al. 2013). In contrast with our results, that showed no changes in β-catenin levels in acute-
treated animals compared to control; the data presented in those studies would imply a decrease in β-
catenin. This discrepancy could be linked  to the way we sampled the area, since we took the whole 
NAcc instead of discriminating core and shell, or to the sensitivity of the quantification method used 
by Miller et al (2014). Nevertheless, as we mentioned, none of them proposed a link between these 
changes in GSK3β activity and the Wnt/β-catenin pathway. Recently, one study found that 24hs after 
a chronic cocaine treatment, the mRNA expression of  Wnt1 and DVL-2 is decreased as well as the 
protein levels of  DVL-2, in the  NAcc core (Dias et al. 2015). However, and in line with our previous 
results (Cuesta et al. 2016), they could not find any changes in β-catenin levels in the NAcc. 
 
Cocaine-induced changes in Wnt/β-catenin pathway activity could be linked to the dopaminergic 
and/or the glutamatergic neurotransmission. 
  In the past decade, a relationship between dopamine neurotransmission and intracellular effectors of 
the Wnt/β-catenin pathway has been shown (Alimohamad et al. 2005b, Peng et al. 2009, Alimohamad 
et al. 2005a, Sutton et al. 2007). Taking into account the mounting evidence about changes in 
dopamine and glutamate neurotransmission that underlies cocaine induced long-term 
neuroadaptations in the NAcc (Kalivas & Volkow 2011, Steketee & Kalivas 2011, Russo et al. 2010), 
it is possible that cocaine-induced changes in Wnt/β-catenin pathway activity could be linked to them. 
For instance, it has been shown that D1 receptor agonist (SKF83959) causes an inhibition of GSK3β 
activity in neuronal cell culture (Yu et al. 2008). Considering that after a period of abstinence from  
repeated cocaine D1 receptors exhibited supersensitivity in the NAcc (Henry & White 1991, White et 
al. 1995) and that the drug challenge leads to an exacerbated DA release in this area (Williams et al. 
1996, Kalivas & Duffy 1993), it is likely that the activation of D1R causes the accumulation of β-
catenin through inhibition of GSK3β. On the other hand, the increase in the release of glutamate 
induced by a cocaine challenge after withdrawal (Baker et al. 2003b, Pierce et al. 1996) could also be 
involved, since it has been found that rats chronically treated with mGluR2/3 agonists showed an 
increase of Wnt canonical pathway effectors (e.g. β-catenin, Dvl-2 and 3, and GSK3β)   in PFC and 
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striatum (Sutton & Rushlow 2011). In addition, recently  Peng et al (2009) showed that the over 
expression of β-catenin in hippocampal cell cultures mimics the effect of increased neuronal activity 
increasing the total dendritic length and decreasing the density of surface synaptic AMPAR clusters, 
as well as scaling down mEPSC amplitudes. Intriguingly, after 3 weeks of withdrawal the surface 
expression of AMPAR is increased in the NAcc, while a cocaine challenge lead to a decrease, only in 
those animals that expressed behavioral sensitization after the challenge (Boudreau et al., 2007; 
Boudreau and Wolf, 2005; Thomas et al., 2001). Then, according to Peng et al (2009), cocaine-
induced increase in β-catenin could be linked to the surface decrease of AMPA R found in animals 
that expressed behavioral sensitization. As mentioned before, our results indicate that increased levels 
of β-catenin in the NAcc are linked to both the expression of sensitization as well as to the cocaine 
challenge. Therefore, it is possible that cocaine-induced increase in β-catenin levels is mediated by a 
dopaminergic-glutamatergic interaction in the NAcc; and, that this accumulation of β-catenin in the 
cytoplasm could activate the pathway as well as facilitates the removal of AMPAR from the surface 
after the cocaine challenge. 
 
Regarding the CPu, we found that a cocaine challenge is linked to a decrease of β-catenin levels in 
those animals that showed behavioral sensitization compared to controls, and stayed similar to 
controls when they did not express sensitization in response to cocaine. Moreover, after 3 weeks of 
abstinence β-catenin was significantly increased compared to controls. Taken together, these results 
suggest that behavioral sensitization requires a reduction in β-catenin, below basal levels, in order to 
manifest. These changes in β-catenin, and probably in the activity of the Wnt canonical pathway, 
might be mediated by the dopaminergic transmission through D2R. Preclinical studies in non-human 
primates have shown that repeated drug exposure is associated with reductions in striatal D2R levels 
(Nader et al. 2006). Considering that the antagonism of D2R is linked to β-catenin accumulation 
(Alimohamad et al. 2005b); while a D2R activation is associated with β-catenin degradation (Min et 
al. 2011), it is possible that the reduction in D2R levels due to repeated cocaine exposure could 
facilitate the accumulation of β-catenin found in the CPu of abstinent animals. Interestingly, we 
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previously showed that a similar reduction on β-catenin was present after 7 days of a chronic cocaine 
treatment and was not related with changes in the activity of Wnt canonical pathway (Cuesta et al 
2016). However, the fact that β-catenin levels in CPu increase during abstinence while decrease after 
a challenge may suggest that changes in the activity of the Wnt canonical pathway could be 
characteristic of the long-term neuroadaptations.  Since our present evidence is not enough to either 
support or reject this hypothesis, further work must be done to fully clarify the role of this pathway in 
the CPu. 
In the case of PFC, our previous results have shown that cocaine induced changes in Wnt canonical 
pathway immediately after the chronic treatment were essential for the  behavioral sensitization 
(Cuesta et al. 2016). Here we showed that the day after a cocaine challenge on day 28, β-catenin 
levels are similar to controls regardless of the behavioral measurement. Interestingly, as in the CPu, 
after the period of abstinence β-catenin levels were increased compared to the control group. 
However, in the PFC the cocaine challenge fails to reduce β-catenin below control level, despite the 
behavioral outcome (sensitized or non-sensitized). It is possible that D2R are involved in this 
mechanism as well; however; more work needs to be done to establish the relevance of these changes 
in cocaine-induced long-term neuroadaptations. 
 
Long term effects of LiCl on cocaine-induced neuroplasticity  
We have previously demonstrated that LiCl administered before each cocaine injection prevented 
the development of sensitization by restoring β-catenin levels in PFC, CPu and Amygdala (Cuesta et 
al. 2016). In the present work, we wanted to evaluate the impact of this treatment on cocaine-induced 
long-term neuroadaptations. We found that LiCl alone not only caused a long-term increase in β-
catenin levels in NAcc, but also blocked the changes observed in CPu and PFC. While administered 
before cocaine, LiCl prevented the expression of behavioral sensitization keeping the levels of β-
catenin increased in the NAcc after the cocaine challenge. Moreover, the long-term changes induced 
by LiCl in the Wnt canonical pathway that prevent cocaine enduring neuroadaptations did not avoid 
the acute effect of the drug. As we argued above, the increase   in the levels of β-catenin in the NAcc 
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together with a decrease in the levels in the CPu compared to control animals were correlated to the 
behavioral changes. In this scenario, the LiCl results seemed contradictory at first glance. However, if 
we take into account that it is the fold-change of β-catenin that dictates Wnt pathway activity and not 
the absolute level (Goentoro & Kirschner 2009); then the LiCl results strengthen our previous 
assumptions that it is the change in β-catenin  and the consequent activation of the canonical pathway 
that matters for the expression of sensitization. To our knowledge, this is the first evidence of LiCl 
long-term molecular effects on GSK3β inhibition, keeping β-catenin levels increased. In addition, this 
is the first time that data reported that  LiCl has a long-term effect on cocaine induced behavioral as 
well as on molecular neuroadaptations. The mechanism associated with LiCl long-term effect on 
cocaine induced behavioral neuroplasticity might involve distinct effects in the different areas of the 
motivational circuitry. We have shown that the activation of the canonical Wnt pathway blocks the 
development of behavioral sensitization by restoring the levels of β-catenin in the PFC and the CPu 
(Cuesta et al. 2016). These restorations could interfere with the subsequent long-term effects of 
cocaine. Furthermore, in the present study we showed that LiCl induced an increase in NAcc’s β-
catenin levels visible up to 3 weeks after the end of the treatment. So, it is possible that the long- 
lasting higher levels of β-catenin may reduce the NAcc AMPAR surface expression (Peng et al. 2009) 
as well as the response to the drug during the expression of cocaine sensitization. According to recent 
evidence, it is also possible that LiCl decreased DA release in the NAcc in response to cocaine (Can et 
al. 2016).  
 
Conclusions 
Understanding the long-term neuroadaptations induced by drugs of abuse is fundamental for the 
development of more successful therapies. In the present work, we propose that the long-term 
activation of the Wnt/β-catenin pathway may be helpful to prevent some cocaine-induced 
neuroadaptations. Even though it is necessary to study this possibility in animal models of 
reinstatement/relapse, the introduction of the Wnt canonical pathway as a possible option opens a new 
door in terms of addiction treatment medication.  
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LEGENDS   
Fig 1. Schematic descriptions of the treatments. A) Adult rats received one injection per day for 7 
days, 3 weeks of abstinence and a final challenge on day 28. Saline group: all saline injections. 
Acute cocaine: received saline. Chronic cocaine: received all cocaine injections. Cocaine/Saline: 
received cocaine on days 1 to 7, and saline on day 28. On days 1,7 and 28 all rats were behaviorally 
tested immediately after the injection. The white syringe represents the saline injection (1 ml/kg), the 
grey one represents cocaine in a 15 mg/kg dose and the black one represents cocaine in a 30 mg/kg 
dose. B) In the chronic cocaine group, their locomotor responses on each day were compared and 
animals were divided into Sensitized (S) and Non-sensitized (NS).   
 
Fig.2 Long-term cocaine-induced neuroadaptations lead to changes in β-catenin expression in 
NAcc. A) First, the levels of β-catenin in the control groups (saline and acute cocaine) were compared 
against the chronic cocaine group that sensitized (chronic cocaine (S)). B) Secondly, in order to study 
if the changes in β-catenin were related to the cocaine treatment only or to the behavioral display of 
sensitization, levels of β-catenin in rats from the chronic cocaine group that showed the expression of 
sensitization were compared with those rats that did not sensitize (NS). C) Finally, we evaluated if the 
changes in β-catenin levels needed the cocaine challenge to appear. Then, the effect of cocaine 
(chronic cocaine (S)) on β-catenin levels was compared to a saline (Coc/Sal) challenge on day 28 in a 
group of animals chronically treated with cocaine. Bars represent Mean ± SEM from β-catenin levels 
in the NAcc. Number of animals (n) is represented inside each bar. *Significantly different from all 
the other groups, p < 0.05. Bonferroni post hoc test.    
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Fig 3. Cocaine-induced behavioral neuroadaptations are associated with a functional increase of β-
catenin in the NAcc 
A) GSK3β activity levels were measured by comparing GSK3β phosphorylated in Y216 and 
Total GSK3β in the NAcc of control and sensitized animals. B) β-catenin levels in the nuclear 
fraction of the NAcc obtained by subcellular fractionation of control and sensitized animals. 
Bars represent Mean ± SEM. Number of animals per group: 6. *Significantly different from 
Saline treatment, p < 0.05; t test.  
 
Fig 4. A repeated treatment with systemic Lithium Chloride along with cocaine blocks the 
expression of cocaine–induced behavioral neuroadaptations. A) Schematic description of the LiCl 
pre-treatment: animals were pretreated with LiCl (30mg/kg i.p.) or vehicle (saline, 1ml/kg i.p.) 30 min 
before each injection of cocaine or saline; and their locomotor activity was tested after injection on 
days 1,7, and 28. B) Total locomotor activity measured on day 28 showed that cocaine induced the 
behavioral expression of sensitization in animals pretreated with saline while LiCl pretreatment 
blocked it. Bars represent Mean ± SEM. Number of animals per group: 6-8. *Significantly different 
Sal/Sal/Sal, p < 0.01; + significantly different from Sal/Sal/Coc, p < 0.01; # significantly different 
from Sal/Coc/Coc, p < 0.05. Holm´s Sidak post hoc test. 
 
Fig. 5. The activation of Wnt/β-catenin pathway during cocaine treatment with LiCl induced long-
term neuroadaptations in β-catenin levels in NAcc. The day after behavioral testing, rats were 
sacrificed and their brains were dissected to measure β-catenin in total homogenates.   Levels of β-
catenin in NAcc total homogenates from animals pretreated with saline was significantly increased in 
the cocaine challenged group; while LiCl pretreated animals showed increase levels of β-catenin in all 
tested groups. Bars represent Mean ± SEM. Number of animals per group: 6-8.  *Significantly 
different from all other saline pretreated groups, p < 0.05; + Significantly different from Sal/Sal/Sal 
group, p < 0.05. Holm´s Sidak post hoc test.  
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Table 1. Levels of β-catenin in total homogenates of brain areas collected after the last injection on 
day 28. A) and B) The levels of β-catenin in the control groups (saline and acute cocaine) were 
compared against the chronic cocaine group that sensitized (chronic cocaine (S)): A) CPu and PFC 
were collected 24hs after the last injection; while in B) NAcc, CPu and PFC were collected 3hs after 
the last injection. C) β-catenin levels in rats that sensitized (S) were compared with those rats that did 
not sensitize (NS). D) Finally, β-catenin levels in chronically treated rats (chronic cocaine (S)) that 
received a cocaine challenge on day 28 were compared to chronically treated rats that received a 
saline challenge (Coc/Sal) on the same day. C) and D) CPu and PFC samples were collected 24hs 
after the last injection. Data represent Mean ± SEM from β-catenin levels. Number of animals per 
group: 6-8. *Significantly different from the rest of the groups, p < 0.05; +Significantly different from 
saline, p < 0.05. Bonferroni post hoc test.    
 
Table 2. Long-term effects of cocaine pretreatment on the levels of β-catenin from total 
homogenates of  CPu and PFC are absent after LiCl pretreatment. Changes in β-catenin levels 
showed after saline pretreatment in PFC and CPu total homogenates (A) were absent in LiCl 
pretreated animals (B). Data in the table represent Mean ± SEM. Number of animals per group: 6-8.  
*Significantly different from all other groups, p < 0.05; + significantly different from Sal/Sal/Sal 
group, p < 0.05. Holm´s Sidak post hoc test.  
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A)  Group 
  Saline Acute Chronic (S) 
B
ra
in
 
ar
ea
 
 
CPu 100.0±2.1 89.4±10.3 60.1±7.9+ 
PFC 100.0±11.1 112.7±6.3 102.8±6.7
B)  Group 
  Saline Acute Chronic (S) 
B
ra
in
 a
re
a 
 
NAcc 100.6±4.4 107.1±5.7 146.6±6.5* 
CPu 100.0±4.6 86.1±5.7 66.68±6.4+ 
PFC 100.7±2.1 104.8±5.1 101.9±8.6 
C)  Group 
  Saline Chronic (S) Chronic (NS) 
B
ra
in
 
ar
ea
 CPu 100.0±2.1 60.1±7.9* 113.1±12.2 
PFC 100.0±11.1 102.8±6.7 105.3±9.2 
D )  Group 
  Saline Chronic (S) Coc/Sal 
B
ra
in
 
ar
ea
 CPu 100.0±2.1 60.1±7.9* 219.4±12.9* 
PFC 100.0±11.1 102.8±6.7 153.6±17.0
+ 
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A) 
Pretreatment Saline 
Treatment Saline Cocaine 
Challenge Saline Cocaine Saline Cocaine 
Group Sal/Sal/Sal Sal/Sal/Coc Sal/Coc/Sal Sal/Coc/Coc 
Br
ai
n 
Ar
ea
 CPu 100.0±4.5 89.4±11.8 219.4±15.3* 60.1±9.2
+ 
PFC 100.0±3.8 112.7±7.4 153.6±3.3+ 104.1±4.5 
 
 
B) 
Pretreatment LiCl 
Treatment Saline Cocaine 
Challenge Saline Cocaine Saline Cocaine 
Group LiCl/Sal/Sal LiCl/Sal/Coc LiCl/Coc/Sal LiCl/Coc/Coc 
Br
ai
n 
Ar
ea
 CPu 152.5±21.9 119.0±10.3 105.1±6.7 137.7±15.3 
PFC 142.0±4.7 133.5±19.2 118.0±8.6 107.0±7.2 
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